Phase II evaluation of maytansine in refractory non-Hodgkin's lymphoma: a Southwest Oncology Group study.

Ratanatharathorn V, Gad-el-Mawla N, Wilson H E, Bonnet J D, Rivkin S E, Mass R

Cancer Treat Rep. 1982 Jul;66(7):1687-8.

Abstract

摘要

相似文献

Cancer Treat Rep. 1982 Jul;66(7):1687-8.

Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1115-7.

Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1953-60.

Cancer Treat Rep. 1980 Apr-May;64(4-5):675-7.

Cancer Treat Rep. 1983 Nov;67(11):1045.

Cancer Clin Trials. 1978 Summer;1(2):113-7.

Cancer Treat Rep. 1981 May-Jun;65(5-6):536-7.

Cancer Treat Rep. 1983 Apr;67(4):401-2.

Cancer Treat Rep. 1980 Apr-May;64(4-5):721-3.

Cancer Treat Rep. 1978 Oct;62(10):1577-9.

Adv Drug Deliv Rev. 2013 Jan;65(1):24-35. doi: 10.1016/j.addr.2012.08.009. Epub 2012 Sep 3.

Cancer Lett. 2011 Aug 28;307(2):113-8. doi: 10.1016/j.canlet.2011.03.017. Epub 2011 Apr 9.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。